Global Suppression of the Host Antiviral Response by Ebola- and Marburgviruses: Increased Antagonism of the Type I Interferon Response Is Associated with Enhanced Virulence
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
We studied the effect of filovirus infection on host cell gene expression by characterizing the regulation of gene expression responses in human liver cells infected with Zaire Ebolavirus (ZEBOV), Reston Ebolavirus (REBOV), and Marburgvirus (MARV), using transcriptional profiling and bioinformatics. Expression microarray analysis demonstrated that filovirus infection resulted in the up-regulation of immune-related genes and the down-regulation of many coagulation and acute-phase proteins. These studies further revealed that a common feature of filovirus virulence is suppression of key cellular antiviral responses, including TLR-, interferon (IFN) regulatory factor 3-, and PKR-related pathways. We further showed that ZEBOV and MARV were more potent antagonists of the IFN response and inhibited the expression of most of the IFN-stimulated genes (ISGs) observed in mock-infected IFN-α-2b treated cells, compared to REBOV infection, which activated more than 20% of these ISGs. Finally, we examined IFN-related gene expression in filovirus-infected cells treated with IFN-α-2b. These experiments revealed that a majority of genes induced in mock-infected cells treated with type I IFN were antagonized in treated ZEBOV- and MARV-infected cells, while in contrast, REBOV infection resulted in a significant increase in ISG expression. Analysis of STAT1 and -2 phosphorylation following IFN treatment showed a significant reduction of STAT phosphorylation for MARV but not for ZEBOV and REBOV, indicating that different mechanisms might be involved in antagonizing IFN signaling pathways by the different filovirus species. Taken together, these studies showed a correlation between antagonism of type I IFN responses and filovirus virulence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data
Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A., Causton, H. C., et al. (2001) · Nature Genetics · doi:10.1038/ng1201-365 · Cited by 4,109
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491 · cited 1×
“It is also possible that other pathways known to interfere with IFN signaling are involved (40).”
BackgroundBaize, S., Leroy, E. M., Georges-Courbot, M.-C., Capron, M., Lansoud-Soukate, J., Debré, P., Fisher-Hoch, S. P., McCormick, J. B., & Georges, A. J. (1999) · Nature Medicine · doi:10.1038/7422 · Cited by 551 · cited 2×
“Defective adaptive immune responses, including impaired humoral responses and apoptosis of B and T cells, have been observed in fatal cases of EBOV infection (2, 3, 18).”
BackgroundA Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515386 · Cited by 492 · cited 1×
“Interestingly, infection of SCID mice with adapted EBOVs causes fatal disease, but the progression of the disease is slowed (9, 25, 42).”
BackgroundThe Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3
Basler, C. F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Mühlberger, E., Bray, M., Klenk, H.-D., Palese, P., & García-Sastre, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7945-7956.2003 · Cited by 477 · cited 10×
“Our array and real-time PCR analysis demonstrated that both ZEBOV and REBOV infection resulted in the increased expression of TF (or F3) and that TF up-regulation was more significant in ZEBOV-infected cells.”
BackgroundSelf-citationThe virus battles: IFN induction of the antiviral state and mechanisms of viral evasion
Levy, D. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00027-7 · Cited by 428 · cited 1×
“In particular, for RNA viruses with relatively small genomes encoding few viral proteins, such as EBOV and influenza virus, control of host cell gene expression is critical for viral fitness (4, 36).”
BackgroundHuman asymptomatic Ebola infection and strong inflammatory response
Leroy, E., Baize, S., Volchkov, V., Fisher-Hoch, S., Georges-Courbot, M.-C., Lansoud-Soukate, J., Capron, M., Debré, P., Georges, A., & McCormick, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02405-3 · Cited by 411 · cited 1×
“Thus, it has been concluded that the progression and ultimate outcome of human clinical filovirus infections are dependent on early antiviral events in EBOV infection that are predicated on the establishment of well-regulated antiviral and immune responses (1, 2, 34, 35, 41).”
BackgroundPreliminary report: isolation of Ebola virus from monkeys imported to USA
Jahrling, P. B., Geisbert, T. W., Johnson, E. D., Peters, C. J., Dalgard, D. W., & Hall, W. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)90737-p · Cited by 403 · cited 1×
“In contrast, Reston EBOV (REBOV), which is lethal in nonhuman primate models (although the time course of the disease is delayed and the number of survivors is higher than that for an infection with ZEBOV), appears to be attenuated in humans (15, 16, 30, 32).”
BackgroundGeisbert, T. W., Hensley, L. E., Jahrling, P. B., Larsen, T., Geisbert, J. B., Paragas, J., Young, H. A., Fredeking, T. M., Rote, W. E., & Vlasuk, G. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15012-x · Cited by 382 · cited 1×
“Additional studies have shown some success in prolonging survival times of EBOV-infected macaques by blocking the coagulation pathway with an inhibitor of the factor VIIa/TF complex (19).”
BackgroundGeiss, G. K., Salvatore, M., Tumpey, T. M., Carter, V. S., Wang, X., Basler, C. F., Taubenberger, J. K., Bumgarner, R. E., Palese, P., Katze, M. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112338099 · Cited by 374 · cited 1×
“Previous work from our laboratory on the pandemic 1918 influenza virus revealed a higher IFN antagonistic activity of the pandemic NS1 protein compared to other H1N1 viruses (24).”
ResultSelf-citationGeisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Kagan, E., & Hensley, L. E. (2003) · The Journal of Infectious Diseases · doi:10.1086/379724 · Cited by 372 · cited 2×
“Recent work has shown that EBOV activates the extrinsic coagulation pathway by stimulating the expression of TF (also known as F3) in primate monocytes (20).”
BackgroundInflammatory responses in Ebola virus-infected patients
BAIZE, S., LEROY, E. M., GEORGES, A. J., GEORGES-COURBOT, M.-C., CAPRON, M., BEDJABAGA, I., LANSOUD-SOUKATE, J., & MAVOUNGOU, E. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01800.x · Cited by 370 · cited 2×
“, tissue factor [TF]), leading to activation of the extrinsic coagulation pathway and ultimately to endothelial cell destruction and permeability (1, 10, 20, 26, 29, 39, 41, 43).”
BackgroundInterferons and Other Cytokines
Hendrzak, J. A., & Brunda, M. J. (1997) · Cancer Therapeutics · doi:10.1007/978-1-59259-717-8_13 · Cited by 356
Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
Mahanty, S., Hutchinson, K., Agarwal, S., Mcrae, M., Rollin, P. E., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2797 · Cited by 354 · cited 1×
“, tissue factor [TF]), leading to activation of the extrinsic coagulation pathway and ultimately to endothelial cell destruction and permeability (1, 10, 20, 26, 29, 39, 41, 43).”
BackgroundPathogenesis of Ebola Hemorrhagic Fever in Primate Models
Geisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Larsen, T., Kagan, E., & Hensley, L. E. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63592-4 · Cited by 318 · cited 1×
“In both primate and human models, most of the major organs, including the liver, lymph nodes, and spleen, show high titers of virus, and immunohistochemical analysis has shown that endothelial and mononuclear cells become heavily infected and play central roles in disease progression (13, 14, 21, 37, 41).”
BackgroundPathogenesis of filoviral haemorrhagic fevers
Mahanty, S., & Bray, M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01103-x · Cited by 310 · cited 2×
“Disease outbreaks associated with the Zaire EBOV (ZEBOV) subtype have resulted in mortality rates of up to 90%; while MARV and Sudan EBOV result in mortality rates of 25 to 90% (38).”
BackgroundVillinger, F., Rollin, P. E., Brar, S. S., Chikkala, N. F., Winter, J., Sundstrom, J. B., Zaki, S. R., Swanepoel, R., Ansari, A. A., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514283 · Cited by 307
Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
Geisbert, T. W., Hensley, L. E., Gibb, T. R., Steele, K. E., Jaax, N. K., & Jahrling, P. B. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780021 · Cited by 302 · cited 1×
“Defective adaptive immune responses, including impaired humoral responses and apoptosis of B and T cells, have been observed in fatal cases of EBOV infection (2, 3, 18).”
BackgroundJahrling, P. B., Geisbert, T. W., Geisbert, J. B., Swearengen, J. R., Bray, M., Jaax, N. K., Huggins, J. W., LeDuc, J. W., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514310 · Cited by 269 · cited 3×
“EBOV infection has been reported to be insensitive to IFN treatment both in vivo and in vitro (28, 31).”
BackgroundMethodFilovirus-induced endothelial leakage triggered by infected monocytes/macrophages
Feldmann, H., Bugany, H., Mahner, F., Klenk, H. D., Drenckhahn, D., & Schnittler, H. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2208-2214.1996 · Cited by 256 · cited 1×
“In both primate and human models, most of the major organs, including the liver, lymph nodes, and spleen, show high titers of virus, and immunohistochemical analysis has shown that endothelial and mononuclear cells become heavily infected and play central roles in disease progression (13, 14, 21, 37, 41).”
BackgroundSelf-citationLarge-Scale Monitoring of Host Cell Gene Expression during HIV-1 Infection Using cDNA Microarrays
Geiss, G. K., Bumgarner, R. E., An, M. C., Agy, M. B., van 't Wout, A. B., Hammersmark, E., Carter, V. S., Upchurch, D., Mullins, J. I., & Katze, M. G. (2000) · Virology · doi:10.1006/viro.1999.0044 · Cited by 246
Self-citationHensley, L. (2002) · Immunology Letters · doi:10.1016/s0165-2478(01)00327-3 · Cited by 242
The role of the Type I interferon response in the resistance of mice to filovirus infection
Bray, M. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-6-1365 · Cited by 228 · cited 1×
“This is in contrast to the case for IFNAR or STAT1 knockout mice, which show increased sensitivity to ZEBOV infection (8).”
ResultGupta, M., Mahanty, S., Ahmed, R., & Rollin, P. E. (2001) · Virology · doi:10.1006/viro.2001.0836 · Cited by 192
Early immune responses accompanying human asymptomatic Ebola infections
Leroy, E. M., Baize, S., Debré, P., Lansoud-Soukate, J., & Mavoungou, E. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01517.x · Cited by 163 · cited 1×
“Thus, it has been concluded that the progression and ultimate outcome of human clinical filovirus infections are dependent on early antiviral events in EBOV infection that are predicated on the establishment of well-regulated antiviral and immune responses (1, 2, 34, 35, 41).”
BackgroundBray, M., Hatfill, S. J., Hensley, L. E., & Huggins, J. W. (2001) · Journal of Comparative Pathology · doi:10.1053/jcpa.2001.0503 · Cited by 162 · cited 1×
“, tissue factor [TF]), leading to activation of the extrinsic coagulation pathway and ultimately to endothelial cell destruction and permeability (1, 10, 20, 26, 29, 39, 41, 43).”
BackgroundMolecular biology and evolution of filoviruses
Feldmann, H., Klenk, H.-D., & Sanchez, A. (1993) · Archives of Virology · doi:10.1007/978-3-7091-9300-6_8 · Cited by 159 · cited 1×
“In contrast, Reston EBOV (REBOV), which is lethal in nonhuman primate models (although the time course of the disease is delayed and the number of survivors is higher than that for an infection with ZEBOV), appears to be attenuated in humans (15, 16, 30, 32).”
BackgroundSelf-citationVIRUSES AND THE TYPE I INTERFERON ANTIVIRAL SYSTEM: INDUCTION AND EVASION
Basler, C. F., & García‐Sastre, A. (2002) · International Reviews of Immunology · doi:10.1080/08830180213277 · Cited by 157 · cited 1×
“In particular, for RNA viruses with relatively small genomes encoding few viral proteins, such as EBOV and influenza virus, control of host cell gene expression is critical for viral fitness (4, 36).”
BackgroundA Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C. S., & Huggins, J. W. (1999) · The Journal of Infectious Diseases · doi:10.1086/514292 · Cited by 153
Pathogenesis of Experimental Ebola Zaire Virus Infection in BALB/c Mice
Gibb, T. R., Bray, M., Geisbert, T. W., Steele, K. E., Kell, W. M., Davis, K. J., & Jaax, N. K. (2001) · Journal of Comparative Pathology · doi:10.1053/jcpa.2001.0502 · Cited by 144 · cited 1×
“Interestingly, infection of SCID mice with adapted EBOVs causes fatal disease, but the progression of the disease is slowed (9, 25, 42).”
BackgroundLukashevich, I. S., Maryankova, R., Владыко, А. С., Nashkevich, N., Koleda, S., Djavani, M. M., Horejsh, D., Voitenok, N. N., & Salvato, M. S. (1999) · Journal of Medical Virology · Cited by 138
Geiss, G. K., An, M. C., Bumgarner, R. E., Hammersmark, E., Cunningham, D. M., & Katze, M. G. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4321-4331.2001 · Cited by 127
Self-citationDavis, K. J., Anderson, A. O., Geisbert, T. W., Steele, K. E., Geisbert, J. B., Vogel, P., Connolly, B., Huggins, J. W., Jahrling, P. B., & Jaax, N. K. (1997) · PubMed · Cited by 123
Harcourt, B. H., Sanchez, A., & Offermann, M. K. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3491-3496.1999 · Cited by 121 · cited 4×
“EBOV infection has been reported to be insensitive to IFN treatment both in vivo and in vitro (28, 31).”
BackgroundInfluentialMolecular Pathogenesis of Filovirus Infections: Role of Macrophages and Endothelial Cells
Schnittler, H., & Feldmann, H. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59949-1_10 · Cited by 96 · cited 3×
“In both primate and human models, most of the major organs, including the liver, lymph nodes, and spleen, show high titers of virus, and immunohistochemical analysis has shown that endothelial and mononuclear cells become heavily infected and play central roles in disease progression (13, 14, 21, 37, 41).”
BackgroundEbola Virus Inhibits Induction of Genes by Double-Stranded RNA in Endothelial Cells
Harcourt, B. H., Sanchez, A., & Offermann, M. K. (1998) · Virology · doi:10.1006/viro.1998.9446 · Cited by 93 · cited 2×
“showed that ZEBOV was a potent antagonist of the double-stranded RNA (dsRNA) response in human umbilical vein endothelial cells (HUVECs) (27).”
Background(2004) · doi:10.1016/j.virol.2004.11.018 · Cited by 82 · cited 3×
“This attenuated phenotype is reflected in cell culture modes, where REBOV shows a clear growth impairment compared to ZEBOV (7).”
BackgroundResultApoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?
Baize, S., Leroy, E. M., Mavoungou, E., & Fisher‐Hoch, S. P. (2000) · APOPTOSIS · doi:10.1023/a:1009657006550 · Cited by 72
Garcin, D., Marq, J., Goodbourn, S., & Kolakofsky, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2321-2329.2003 · Cited by 60 · cited 1×
“It is reported that expression of SeV C protein leads to increased STAT1 phosphorylation, whereas STAT2 is not phosphorylated at all (17, 33).”
BackgroundKato, A., Grogan, C. C., Moyer, S. A., Sugahara, F., Sakaguchi, T., Kubota, T., Otsuki, N., Kohase, M., Tashiro, M., & Nagai, Y. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7443-7454.2004 · Cited by 49 · cited 2×
“It is reported that expression of SeV C protein leads to increased STAT1 phosphorylation, whereas STAT2 is not phosphorylated at all (17, 33).”
Background
Cited by
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934
Self-citationGenomic analysis of increased host immune and cell death responses induced by 1918 influenza virus
Kash, J. C., Tumpey, T. M., Proll, S. C., Carter, V., Perwitasari, O., Thomas, M. J., Basler, C. F., Palese, P., Taubenberger, J. K., García-Sastre, A., et al. (2006) · Nature · doi:10.1038/nature05181 · Cited by 551
Self-citationAntiviral activities of type I interferons to SARS-CoV-2 infection
Mantlo, E., Bukreyeva, N., Maruyama, J., Paessler, S., & Huang, C. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104811 · Cited by 426
Wauquier, N., Becquart, P., Padilla, C., Baize, S., & Leroy, E. M. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000837 · Cited by 377
Frieman, M., Ratia, K., Johnston, R. E., Mesecar, A. D., & Baric, R. S. (2009) · Journal of Virology · doi:10.1128/jvi.02220-08 · Cited by 368
Metadata
- Authors
- Kash, J. C., Mühlberger, E., Carter, V., Grosch, M., Perwitasari, O., Proll, S. C., Thomas, M. J., Weber, F., Klenk, H.-D., & Katze, M. G.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-03-15
- Volume
- 80
- Issue
- 6
- Pages
- 3009-3020
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2160999690
- Cited by
- 175
- References
- 41
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.